SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. The firm offers vehicle sellers a full range of services to process and sell vehicles primarily over the internet through Virtual Bidding Third Generation Internet auction-style sales technology. It sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters and at certain locations, and the public. The company’s services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, and vehicle processing programs. It operates through the United States and International segments. The company was founded by Willis J. Johnson in 1982 and is headquartered in Dallas, TX.

Copart, Inc.

Copart is trending as traders assess whether the stock is oversold and poised for a bounce, given its recent consolidation at long-term lows. The community highlights Copart's competitive advantages, including high barriers to entry, network effects, and AI integration, while also weighing risks such as rising operating costs and increased competition. Bullish investors are optimistic about potential catalysts like margin expansion and growth in higher-margin services.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to renewed interest in its rare earth verification technology following presentations in Dubai, potentially leading to increased adoption. Community members are actively discussing the possibility of a short squeeze and high volatility, while some warn of potential dilution from share additions. The stock's low float and recent reverse splits contribute to its volatile price action, with speculation about further runs.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around the project, emphasizing its resilience and ongoing development efforts despite recent setbacks from early investors selling. Community members are actively discussing the potential for a significant recovery and highlighting the project's utilities, NFT rewards, and staking features. Bullish community members are focused on building, holding, and uniting with other meme communities to take BROKE to the moon.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as concerns rise around global liquidity due to increasing Japanese bond yields and potential impacts from the Yen carry trade unwind. Community members are actively discussing the possibility of a significant market correction, watching key support levels, and debating whether this pullback is a buying opportunity or the start of a larger downturn.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid renewed interest from Michael Burry, who hinted at releasing the full GME story, sparking speculation about a potential return to a bullish stance. The community is buzzing about upcoming earnings and the possibility of a significant move, drawing comparisons to past meme stock rallies. Some traders are pointing to the company's cash position and digital transformation as reasons for optimism.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors await the release of topline data from its HOPE-3 Phase 3 trial for Duchenne muscular dystrophy, with the community actively debating the potential outcomes. Discussions involve speculation on FDA approval pathways based on LVEF data, comparisons to competitor SRPT, and analysis of short-selling activity, including a recent report from Martin Shkreli. Community sentiment is divided, with bulls expressing confidence in positive results and bears highlighting potential risks.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

WDAY is trending due to a mix of factors, including analyst rating adjustments and upcoming earnings. Community discussions revolve around AI integration, growth potential, and comparisons to sector peers like PLTR, ZS and CRM. Technical analysis suggests key support and resistance levels are being closely watched amid fluctuating market sentiment.

Tidal Trust II - YieldMax MSTR Short Option Income Strategy ETF

YieldMax MSTR Short Option Income Strategy ETF

WNTR is experiencing a surge in trading volume, despite a slight price decrease, leading to speculation about strategic accumulation and potential hedging activity related to MSTR. Community members are actively discussing the ETF's dividend payouts in relation to its inverse pair, MSTY, and are weighing the benefits of holding both to capture yield and hedge against volatility in MSTR. Some investors are using WNTR's distributions to strategically reinvest in MSTY when it dips, further highlighting its role as a balancing component in a broader investment approach.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending amid discussions around its strategic moves in the crypto space with the launch of KlarnaUSD, and potential impacts on the traditional banking sector. Community members are also discussing Klarna's partnerships with Google and Lufthansa, as well as positive Black Friday sales data and anticipation of future rate cuts. Despite positive developments, some express concerns over the stock's performance and broader economic conditions.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

ProShares Ultra Semiconductors ($USD) is trending as discussions around market structure and potential shifts to bull domination gain traction within the community. Some traders are pointing to technical indicators and broader market analysis to support their bullish outlook on semiconductors. Investors are also weighing in on the ETF's suitability for long-term investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research note on Friday...

Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200 Day Moving Average on Insider Selling

Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above Two Hundred Day Moving Average After Insider Selling...

Spero Therapeutics (NASDAQ:SPRO) Issues Earnings Results, Beats Estimates By $0.12 EPS

Spero Therapeutics (NASDAQ:SPRO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by...

Spero Therapeutics (NASDAQ:SPRO) Insider Esther Rajavelu Sells 40,270 Shares

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of...

Spero Therapeutics (NASDAQ:SPRO) Insider Sells $95,439.90 in Stock

Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) insider Esther Rajavelu sold 40,270 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold...

Best Momentum Stock to Buy for October 10th

SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease 

BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround 

The heavy selling pressure might have exhausted for Spero Therapeutics (SPRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease

BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.

AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

Spero Therapeutics Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

SPRO
Spero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SPRO News

SPROSpero Therapeutics Inc